Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity

Recruiting N/A Interventional Study
Atrial Fibrillation (AF)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
1,000 (estimated)
Sponsor
University of California, San Francisco · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Per the 2021 National Survey on Drug Use and Health administered by the U.S. Department of Health and Human Services, 85% of all American adults consume alcohol. Atrial fibrillation (AF) is the most common arrhythmia, affecting more than 10 million individuals in U.S., comprising 4.5% of the adult population. Although alcohol abstinence clearly reduces AF in heavy drinkers, observational data comp…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Are age 21 years or older * Have a smartphone * Are able to use the Eureka mobile application * Have a history of paroxysmal or persistent atrial fibrillation (AF) * Have consumed alcohol at least once per month on average in the past year * Willing to receive messaging encour…
Contacts

Gregory M Marcus, MD, MAS

415-476-5706

greg.marcus@ucsf.edu

CONTACT

Gabrielle C Montenegro, BA

415-502-3053

gabby.montenegro2@ucsf.edu

CONTACT